| Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ... The Lancet 378 (9800), 1396-1407, 2011 | 1381 | 2011 |
| Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients AS Greenstein, K Khavandi, SB Withers, K Sonoyama, O Clancy, ... Circulation 119 (12), 1661-1670, 2009 | 698 | 2009 |
| Diabetic cardiomyopathy O Asghar, A Al-Sunni, K Khavandi, A Khavandi, S Withers, A Greenstein, ... Clinical science 116 (10), 741-760, 2009 | 280 | 2009 |
| Dispelling the myth: the use of renin–angiotensin blockade in atheromatous renovascular disease C Chrysochou, RN Foley, JF Young, K Khavandi, CM Cheung, PA Kalra Nephrology Dialysis Transplantation 27 (4), 1403-1409, 2012 | 123 | 2012 |
| The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease PA Kalra, C Chrysochou, D Green, CM Cheung, K Khavandi, S Sixt, ... Catheterization and Cardiovascular Interventions 75 (1), 1-10, 2010 | 117 | 2010 |
| Diabetic cardiomyopathy–a distinct disease? K Khavandi, A Khavandi, O Asghar, A Greenstein, S Withers, ... Best practice & research Clinical endocrinology & metabolism 23 (3), 347-360, 2009 | 111 | 2009 |
| Cardiovascular disease in chronic kidney disease: untying the Gordian knot R Hajhosseiny, K Khavandi, DJ Goldsmith International journal of clinical practice 67 (1), 14-31, 2013 | 88 | 2013 |
| Vascular remodeling: implications for small artery function and target organ damage K Sonoyama, A Greenstein, A Price, K Khavandi, T Heagerty Therapeutic advances in cardiovascular disease 1 (2), 129-137, 2007 | 84 | 2007 |
| Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study E Nikiphorou, S de Lusignan, CD Mallen, K Khavandi, G Bedarida, ... Heart 106 (20), 1566-1572, 2020 | 80 | 2020 |
| Strategies for preventing type 2 diabetes: an update for clinicians K Khavandi, H Amer, B Ibrahim, J Brownrigg Therapeutic advances in chronic disease 4 (5), 242-261, 2013 | 71 | 2013 |
| Myogenic tone and small artery remodelling: insight into diabetic nephropathy K Khavandi, AS Greenstein, K Sonoyama, S Withers, A Price, RA Malik, ... Nephrology Dialysis Transplantation 24 (2), 361-369, 2009 | 64 | 2009 |
| Oral anticoagulants for Asian patients with atrial fibrillation I Sabir, K Khavandi, J Brownrigg, AJ Camm Nature reviews cardiology 11 (5), 290-303, 2014 | 59 | 2014 |
| Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels K Khavandi, RL Baylie, SA Sugden, M Ahmed, V Csato, P Eaton, ... Science signaling 9 (449), ra100-ra100, 2016 | 52 | 2016 |
| Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study E Nikiphorou, S De Lusignan, C Mallen, J Roberts, K Khavandi, ... Rheumatology 59 (6), 1296-1305, 2020 | 44 | 2020 |
| Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study J Galloway, K Barrett, P Irving, K Khavandi, M Nijher, R Nicholson, ... RMD open 6 (3), e001392, 2020 | 36 | 2020 |
| Eutrophic remodeling of small arteries in type 1 diabetes mellitus is enabled by metabolic control: a 10-year follow-up study AS Greenstein, A Price, K Sonoyama, A Paisley, K Khavandi, S Withers, ... Hypertension 54 (1), 134-141, 2009 | 31 | 2009 |
| Have we reached the limits for the treatment of diabetic nephropathy? R Hajhosseiny, K Khavandi, N Jivraj, S Mashayekhi, DJ Goldsmith, ... Expert opinion on investigational drugs 23 (4), 511-522, 2014 | 27 | 2014 |
| Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study E Nikiphorou, S de Lusignan, C Mallen, K Khavandi, J Roberts, ... Rheumatology 59 (5), 997-1005, 2020 | 25 | 2020 |
| Retinal arterial hypertrophy: the new LVH? K Khavandi, M Arunakirinathan, AS Greenstein, AM Heagerty Current hypertension reports 15, 244-252, 2013 | 17 | 2013 |
| The ebbs and flows in the development of cholesterol‐lowering drugs: prospects for the future R Hajhosseiny, I Sabir, K Khavandi, AS Wierzbicki Clinical Pharmacology & Therapeutics 96 (1), 64-73, 2014 | 15 | 2014 |
